ATOS
Atossa Genetics Inc
NASDAQ: ATOS · HEALTHCARE · BIOTECHNOLOGY
$5.37
+1.70% today
Updated 2026-04-30
Market cap
$49.09M
P/E ratio
—
P/S ratio
1,872.06x
EPS (TTM)
$-4.04
Dividend yield
—
52W range
$4 – $19
Volume
0.1M
Atossa Genetics Inc (ATOS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1500.00 | $481842.00 | $632558.00 | $40138.00 | $1758.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | +32022.8% | +31.3% | -93.7% | -95.6% | -100.0% | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | $97190.00 | $65629.00 | $495465.00 | $340658.00 | $132411.00 | $303482.00 | $128994.00 | $44197.00 | $52789.00 | $46600.00 | $23000.00 | $8000.00 | $23000.00 | $17000.00 | $16000.00 |
| Gross profit | — | — | $-95690.00 | $416213.00 | $137093.00 | $40138.00 | $-130653.00 | $-303482.00 | $-128994.00 | $-44197.00 | $-52789.00 | $-46600.00 | $-23000.00 | $-8000.00 | $-23000.00 | $-17000.00 | $-16000.00 |
| Gross margin | — | — | -6379.3% | 86.4% | 21.7% | 100.0% | -7431.9% | — | — | — | — | — | — | — | — | — | — |
| R&D | $21250.00 | $119996.00 | — | $1974.00 | $1.11M | $2.58M | $2.36M | $770427.00 | $2.33M | $4.21M | $7.13M | $6.61M | $9.21M | $15.08M | $17.33M | $14.12M | $21.18M |
| SG&A | — | $882158.00 | $3.17M | $5.02M | $8.56M | $8.63M | $8.85M | $6.48M | $4.86M | $7.22M | $10.62M | $8.00M | $11.31M | $12.61M | $14.04M | $13.50M | $15.96M |
| Operating income | $-122857.00 | $-1.08M | $-3.43M | $-5.07M | $-10.78M | $-12.17M | $-12.76M | $-7.25M | $-7.19M | $-11.43M | $-17.27M | $-14.61M | $-20.52M | $-27.69M | $-31.38M | $-27.62M | $-37.14M |
| Operating margin | — | — | -228612.7% | -1052.0% | -1704.9% | -30323.0% | -725746.2% | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-122857.00 | $-1.09M | $-3.41M | $-4.94M | $-10.31M | $-9.35M | $-12.49M | $-6.07M | $-7.80M | $-11.39M | $-17.21M | $-14.56M | $-20.50M | $-27.68M | $-31.35M | $-27.60M | $-37.13M |
| EBITDA margin | — | — | -227243.5% | -1024.7% | -1630.1% | -23292.8% | -710238.4% | — | — | — | — | — | — | — | — | — | — |
| EBIT | — | $-1.09M | $-3.42M | $-5.07M | $-10.78M | $-9.82M | $-12.76M | $-6.37M | $-7.93M | $-11.43M | $-17.27M | $-14.61M | $-20.52M | $-27.69M | $-31.38M | $-27.62M | $-37.14M |
| Interest expense | — | $9139.00 | $17992.00 | $12040.00 | $360.00 | $15769.00 | $0.00 | $0.00 | $192817.00 | $0.00 | $0.00 | $938794.00 | $85000.00 | $8000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-122857.00 | $-1.09M | $-3.44M | $-5.08M | $-10.78M | $-14.66M | $-15.76M | $-6.37M | $-8.12M | $-11.40M | $-17.24M | $-17.83M | $-20.61M | $-26.23M | $-30.09M | $-25.50M | $-34.77M |
| Net income growth (YoY) | — | -784.7% | -216.7% | -47.6% | -112.3% | -35.9% | -7.5% | +59.6% | -27.5% | -40.4% | -51.2% | -3.4% | -15.6% | -27.3% | -14.7% | +15.3% | -36.3% |
| Profit margin | — | — | -229484.6% | -1054.3% | -1704.9% | -36518.8% | -896491.6% | — | — | — | — | — | — | — | — | — | — |